fbpx

4

Jul, 2018

The DAWN Trial and how it could affect stroke care at your facility.

By: | Tags: , , , , , | Comments: 0

The Background: The DAWN(DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention with Trevo), was created to measure the effects of stroke treatment in the timeframe outside the AHA and ESO guidelines of 6 hours. Funded by Stryker Neurovascular, Dr. Nogueira and Tudor Jovin, MD were named Coprincipal Investigators and led the DAWN Trial. A 2016 analysis suggested that the benefit…

READ MORE